Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey

Grant Creaney*, Mariél Aquino Goulart , Laura Mendoza, Tom Dudding, Miranda Pring, Et Al

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

Background
Globally, most people with head and neck cancers (HNCs) are diagnosed with advanced-stage disease. HNC diagnostic stage has multifactorial explanations, with the role of health system factors not yet fully investigated.

Methods
HNC centres (n = 18) from the HEADSpAcE Consortium were surveyed via a bespoke health system questionnaire covering a range of factors. Centres were compared using the least square means for the presence/absence of each health system factor to their proportion of advanced-stage HNC.

Results
Health system factors associated with lower proportion in advanced-stage diagnosis were formal referral triaging (14%, 95% CI-0.26, −0.03), routine monitoring of time from referral to diagnosis (16%, 95% CI-0.27, −0.05), and fully publicly funded systems (17%, 95% CI-0.29, −0.06). Several health systems factors had no routinely available data.

Conclusions
Through identifying and monitoring health systems factors associated with lower proportions of advanced stage HNC, interventions could be developed, and systems redesigned, to improve early diagnosis.
Original languageEnglish
JournalHead and Neck
Early online date24 Feb 2025
DOIs
Publication statusE-pub ahead of print - 24 Feb 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). Head & Neck published by Wiley Periodicals LLC.

Fingerprint

Dive into the research topics of 'Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey'. Together they form a unique fingerprint.

Cite this